These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9417095)
1. Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice. Draper LB; Matzuk MM; Roberts VJ; Cox E; Weiss J; Mather JP; Woodruff TK J Biol Chem; 1998 Jan; 273(1):398-403. PubMed ID: 9417095 [TBL] [Abstract][Full Text] [Related]
2. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Chapman SC; Bernard DJ; Jelen J; Woodruff TK Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inhibin signal transduction. Bernard DJ; Chapman SC; Woodruff TK Recent Prog Horm Res; 2001; 56():417-50. PubMed ID: 11237224 [TBL] [Abstract][Full Text] [Related]
4. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684 [TBL] [Abstract][Full Text] [Related]
5. In situ ligand binding of recombinant human [125I] activin-A and recombinant human [125I]inhibin-A to the adult rat ovary. Woodruff TK; Krummen L; McCray G; Mather JP Endocrinology; 1993 Dec; 133(6):2998-3006. PubMed ID: 8243328 [TBL] [Abstract][Full Text] [Related]
6. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731 [TBL] [Abstract][Full Text] [Related]
7. Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers. Zheng W; Sung CJ; Hanna I; DePetris G; Lambert-Messerlian G; Steinhoff M; Lauchlan SC Int J Gynecol Pathol; 1997 Jul; 16(3):263-71. PubMed ID: 9421093 [TBL] [Abstract][Full Text] [Related]
8. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). Chapman SC; Woodruff TK Mol Endocrinol; 2001 Apr; 15(4):668-79. PubMed ID: 11266516 [TBL] [Abstract][Full Text] [Related]
9. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer. Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055 [TBL] [Abstract][Full Text] [Related]
10. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239 [TBL] [Abstract][Full Text] [Related]
11. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793 [TBL] [Abstract][Full Text] [Related]
12. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice. Cipriano SC; Chen L; Kumar TR; Matzuk MM Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231 [TBL] [Abstract][Full Text] [Related]
13. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan. Ethier JF; Farnworth PG; Findlay JK; Ooi GT Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797 [TBL] [Abstract][Full Text] [Related]
15. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. Vänttinen T; Kuulasmaa T; Liu J; Voutilainen R J Clin Endocrinol Metab; 2002 Sep; 87(9):4257-63. PubMed ID: 12213882 [TBL] [Abstract][Full Text] [Related]
16. Alpha 2-macroglobulin is a binding protein of inhibin and activin. Vaughan JM; Vale WW Endocrinology; 1993 May; 132(5):2038-50. PubMed ID: 7682939 [TBL] [Abstract][Full Text] [Related]
17. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein. Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537 [TBL] [Abstract][Full Text] [Related]
18. Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos. Roberts VJ; Bentley CA; Guo Q; Matzuk MM; Woodruff TK Endocrinology; 1996 Oct; 137(10):4201-9. PubMed ID: 8828478 [TBL] [Abstract][Full Text] [Related]
19. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding. Krummen LA; Moore A; Woodruff TK; Covello R; Taylor R; Working P; Mather JP Biol Reprod; 1994 Apr; 50(4):734-44. PubMed ID: 8199254 [TBL] [Abstract][Full Text] [Related]
20. Inhibin binding sites and proteins in pituitary, gonadal, adrenal and bone cells. Farnworth PG; Harrison CA; Leembruggen P; Chan KL; Stanton PG; Ooi GT; Rahman NA; Huhtaniemi IT; Findlay JK; Robertson DM Mol Cell Endocrinol; 2001 Jun; 180(1-2):63-71. PubMed ID: 11451573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]